Inhibition of RAS-targeted prenylation: protein farnesyl transferase inhibitors revisited
- 1 January 2000
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 33 (1) , 7-23
- https://doi.org/10.1016/s1040-8428(99)00053-0
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Increasing complexity of Ras signalingOncogene, 1998
- Non-Ras targets of farnesyltransferase inhibitors: focus on RhoOncogene, 1998
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- American Association for Cancer Research 1998: promises and prospects for the next centuryExpert Opinion on Investigational Drugs, 1998
- Characterization of Ha-Ras, N-Ras, Ki-Ras4A, and Ki-Ras4B as in Vitro Substrates for Farnesyl Protein Transferase and Geranylgeranyl Protein Transferase Type IJournal of Biological Chemistry, 1997
- Protein Prenylation, et cetera--Signal Transduction in Two DimensionsScience, 1997
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Inhibitors of the Ras Signal Transduction Pathway as Potential Antitumour AgentsxJournal of Enzyme Inhibition, 1996
- Polylysine and CVIM Sequences of K-RasB Dictate Specificity of Prenylation and Confer Resistance to Benzodiazepine Peptidomimetic in VitroJournal of Biological Chemistry, 1995
- Selective Inhibition of ras -Dependent Transformation by a Farnesyltransferase InhibitorScience, 1993